The unvaccinated has less than 1% chance of getting COVID.
Here are the numbers from the study.
Comirnaty (BNT162b2, Pfizer-BioNTech) COVID-19 Vaccine
The Pfizer-BioNTech, now called Comirnaty, COVID-19 vaccine was first given Emergency Use Authorization (EUA) on December 11, 2020, and as of May 10, 2021, has been approved for patients 12 years and older and has been administered to over 205 million Americans.3,4 On August 23, 2021, Comirnaty became the first FDA-approved COVID-19 vaccine for patients 16 years and older.4 This recommendation came from results of a phase 2/3 ongoing multinational, placebo-controlled, observer-blinded, trial of Comirnaty. Primary end points were efficacy of the vaccine against laboratory-confirmed COVID-19 and safety. A total of 43,548 participants (≥ 16 years) from 152 sites worldwide were randomized 1:1 to receive 2 doses, 21 days apart, of either placebo or Comirnaty (30 μg/dose).5 The primary efficacy end point was achieved in 8 patients in the Comirnaty group (0.04%) and 162 patients in the placebo group (0.88%). This corresponds with the vaccine being 95% effective in preventing COVID-19 (95% CI, 90.3%-97.6%).5
COVID-19 Vaccines: FDA Approved, EUA, and in the Pipeline
Clinical testing of COVID-19 vaccine efficacy has led to the first FDA-approved COVID-19 vaccine, Comirnaty.www.pharmacytimes.com
I'm doing what I can to be sure that I'm not in that percentage that does.
As someone who is in the medical field and has moderate to severe asthma, the vaccine is a given for me.
You can stop trying to dissaude me from the vaccine. It will never happen! For me the benefits far outweigh the risks.